@article{meisel_narrative_2011,
	title = {Narrative vs Evidence-Based Medicine—And, Not Or},
	volume = {306},
	url = {http://jama.ama-assn.org/content/306/18/2022.extract},
	doi = {10.1001/jama.2011.1648},
	abstract = {Excerpt: "The week before the {US} Preventive Services Task Force ({USPSTF}) released its recommendations against routine prostate screening for healthy men, celebrity patients including Joe Torre and Rudy Giuliani had already lined up to challenge the population-based recommendations. To promote their position that screening for prostate-specific antigen is lifesaving, these individuals relied on a powerful tool: their own personal narratives. However, the experts whose goal is to disseminate and translate population-based evidence will, in the name of science, shun individual stories. This one-sided use of narrative has played out repeatedly, from the {USPSTF} recommendations on screening mammography to the {US} Food and Drug Administration ({FDA}) labeling hearings on bevacizumab for advanced breast cancer.1,2 Each time, those who espouse only evidence—without narratives about real people—struggle to control the debate. Typically, they lose."},
	pages = {2022 --2023},
	number = {18},
	journaltitle = {{JAMA}: The Journal of the American Medical Association},
	author = {Meisel, Zachary F. and Karlawish, Jason},
	urldate = {2011-11-09},
	date = {2011-11-09}
}

